Tavares-Da-Silva, Fernanda http://orcid.org/0000-0003-2411-8065
Mahaux, Olivia http://orcid.org/0000-0002-9361-3118
Van Holle, Lionel http://orcid.org/0000-0001-7354-6475
Haguinet, François http://orcid.org/0000-0003-4989-3738
Seifert, Harry http://orcid.org/0000-0001-8048-5885
Stegmann, Jens-Ulrich http://orcid.org/0000-0002-3792-4368
Article History
First Online: 30 August 2020
Declarations
:
: This study was funded by GlaxoSmithKline Biologicals SA. GlaxoSmithKline Biologicals SA also covered the costs associated with the development and publishing of the manuscript.
: FTS, JUS, FH, HAS and OM are employees of the GSK group of companies and FTS, LVH, JUS, FH, HAS and OM hold shares/restricted shares in the GSK group of companies. LVH was employed by the GSK group of companies during the conduct of this study and is a current employee of UCB Pharma. Fernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert and Jens-Ulrich Stegmann have no other conflicts of interest that are directly relevant to the content of this article.
: Not applicable
: Not applicable
: Not applicable
: The data that support the findings of this work are available from the corresponding author on reasonable request.
: Not applicable.
: FTS, LVH, JUS and OM were involved in the conception and design of the study; HAS, FTS, LVH, JUS and OM contributed to the data extraction; FTS, FH and JUS conducted the analyses; and all authors contributed to interpreting the data. All authors reviewed and edited the manuscript. All authors have read and approved the final manuscript. All authors attest they meet the International Committee of Medical Journal Editors criteria for authorship.